Correlation Between AN2 Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Aerovate Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between AN2 and Aerovate is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.29 times more return on investment than Aerovate Therapeutics. However, AN2 Therapeutics is 1.29 times more volatile than Aerovate Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.24 per unit of risk. If you would invest 110.00 in AN2 Therapeutics on August 27, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AN2 Therapeutics vs. Aerovate Therapeutics
Performance |
Timeline |
AN2 Therapeutics |
Aerovate Therapeutics |
AN2 Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |